Absci · pitchdeck
Absci | Investor Presentation Deck | 48 slides
48 pages · 3 arc beats · 2 loops
Absci | Investor Presentation Deck | 48 slides
Absci · 2023-07 arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
124681012141618202224262830323436384042444648
Deck intelligence map
3 coverage by narrative range · generated from this deck JSON
Narrative range 46 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 2 slides 100% 2/2 slides 100% 2/2 slides · 9 hits — 0/2 slides
100% 2/2 slides 100% 2/2 slides 100% 2/2 slides 100% 2/2 slides Agitate 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits — 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Solution 43 slides 100% 43/43 slides 100% 43/43 slides · 218 hits — 0/43 slides
34.9% 15/43 slides 41.9% 18/43 slides 100% 43/43 slides 9.3% 4/43 slides Slide inventory
48 every slide · same image gating as the playbook
01
The slide uses Python-like code snippets to illustrate the technical nature of their drug discovery process.front_matter
03
Uses a rhetorical question to frame the company's value proposition as a paradigm shift.frame_problem
04
Uses a process diagram to illustrate the iterative, inefficient nature of traditional drug discovery.frame_problem
05
Uses a visual comparison between small molecule and biologic data availability to frame the problem.frame_problem
06
The slide uses a process flow to explain the technical solution.present_solution
Open slide detailBeat · Solution
07
The slide uses a metaphor to frame the company's value proposition against the backdrop of low clinical trial success rates.frame_problem
Open slide detailBeat · Solution
08
The slide uses a flywheel-style diagram to represent the iterative nature of the platform.present_solution
Open slide detailBeat · Solution
09
The diagram represents a flywheel or iterative process loop.show_traction
Open slide detailBeat · Solution
10
The slide uses a linear process flow to demonstrate the integration of AI across the drug discovery and development lifecycle.present_solution
Open slide detailBeat · Solution
11
The 'o' in 'zero-shot' is replaced by a molecular/network graphic.present_solution
Open slide detailBeat · Solution
12
The slide outlines a technical workflow involving AI-driven antibody design and subsequent experimental validation.present_solution
Open slide detailBeat · Solution
13
The slide uses a 5-step process flow diagram to explain the technical methodology.present_solution
Open slide detailBeat · Solution
14
The slide highlights the efficacy of the de novo design model by showing a histogram of binding affinities and key performance metrics.show_traction
Open slide detailBeat · Solution
15
The slide uses a case study format to validate the efficacy of the company's AI platform.show_traction
Open slide detailBeat · Solution
16
The heatmap shows edit distance between pairs of HCDR3 sequences; the table shows specific examples of designed sequences and their binding affinity (-Log10 Kd)analyze_data
Open slide detailBeat · Solution
17
The slide highlights the 'zero-shot' nature of the model, emphasizing the lack of lead optimization and the successful application across four distinct therapeuillustrate_case
Open slide detailBeat · Solution
18
The slide showcases structural biology models of AI-designed antibodies (heavy/light chains) binding to specific antigens.present_solution
Open slide detailBeat · Solution
19
The slide uses a pull-quote from a scientific paper to establish authority.inspire_vision
Open slide detailBeat · Solution
20
The slide uses a linear process flow to demonstrate the integration of AI into drug discovery.present_solution
Open slide detailBeat · Solution
21
Uses a Venn diagram to represent the intersection of three properties optimized by AI.present_solution
Open slide detailBeat · Solution
22
The slide uses a visual comparison between a small sampled space (50k) and a massive hypothetical space (7x10^6) to illustrate the efficiency of the AI approachillustrate_case
Open slide detailBeat · Solution
23
Case study slide showing correlation metrics (Pearson, Spearman, RMSE) and a histogram comparing predicted affinity to Trastuzumab.show_traction
Open slide detailBeat · Solution
24
The slide uses a process flow diagram to show AI input leading to an antibody structure, which then branches into three key benefits.present_solution
Open slide detailBeat · Solution
25
The slide uses two line charts to show optimization over generations and a scatter plot to show the distribution of variants.present_solution
Open slide detailBeat · Solution
26
The slide uses a histogram to visualize the distribution of binding affinity (-log10(KD)) for designed variants compared to the wild-type Trastuzumab baseline.show_traction
Open slide detailBeat · Solution
27
Uses a tripartite structure to show application areas for multi-valent binding.present_solution
Open slide detailBeat · Solution
28
The slide uses a linear process flow to explain the company's core technology platform.present_solution
Open slide detailBeat · Solution
29
The letter 'o' in 'potential' is replaced by the company's circular logo graphic.transition
Open slide detailBeat · Solution
30
Includes a biological diagram of TLS and a Kaplan-Meier survival curve.show_traction
Open slide detailBeat · Solution
31
The slide uses a clear, linear process flow with icons to represent each stage of the R&D pipeline.present_solution
Open slide detailBeat · Solution
32
The slide highlights the scale of the antibody discovery pipeline and the distribution of therapeutic focus areas.show_traction
Open slide detailBeat · Solution
33
The slide uses a two-column layout to contrast the partners (left) with the value derived from those partnerships (right).show_traction
Open slide detailBeat · Solution
34
The slide uses a linear process flow to demonstrate the platform's capabilities.present_solution
Open slide detailBeat · Solution
35
The slide explains the mechanism of incorporating nsAA into mAbs to create ADC precursors.present_solution
Open slide detailBeat · Solution
36
The slide uses a split-column layout to contrast the platform's technical capability with its practical application.present_solution
Open slide detailBeat · Solution
37
The slide uses a series of diagrams to illustrate the biological engineering features of the cell line.present_solution
Open slide detailBeat · Solution
38
The slide uses a bar chart to show that even with 3 nsAA sites, the relative expression remains comparable to wild-type, validating the platform's efficiency.show_traction
Open slide detailBeat · Solution
39
The slide uses a mass spectrometry plot to show the shift in molecular mass after conjugation, highlighting the precision of the Absci platform.illustrate_case
Open slide detailBeat · Solution
40
Uses a four-column layout to categorize value propositions.present_solution
41
PoS stands for Probability of Success. The slide uses a timeline framework to contrast traditional drug development with Absci's approach.present_solution
42
Uses a dot-plot style bar chart to represent revenue over a 25-year period.present_solution
45
Includes a dog (Penelope) as 'Chief Morale Officer', a common startup culture trope.other
Open slide detailBeat · Solution
47
The slide uses a growth curve to illustrate technological progression over time.plan_implementation
Open slide detailBeat · Solution
48
The slide uses a high-contrast visual style with a black-and-white lab photo and a stylized red-and-black graphic element.state_next_steps
Open slide detailBeat · Solution